SHF confers radioresistance in colorectal cancer by the regulation of mitochondrial DNA copy number

Clin Exp Med. 2023 Oct;23(6):2457-2471. doi: 10.1007/s10238-022-00969-z. Epub 2022 Dec 17.

Abstract

Altered mitochondrial function contributes greatly to pathogenesis and progression of colorectal cancer. In this study, we report a functional pool of Src homology 2 domain-containing F (SHF) in mitochondria controlling the response of colorectal cancer cells to radiation therapy. We found that elevated expression of SHF in cancer cells is essential for promoting mitochondrial function by increasing mitochondrial DNA copy number, thus reducing the sensitivity of colorectal cancer cells to radiation. Mechanistically, SHF binds to mitochondrial DNA and promotes POLG/SSBP1-mediated mitochondrial DNA synthesis. Importantly, SHF loss-mediated radiosensitization was phenocopied by depletion of mitochondrial DNA. Thus, our data demonstrate that mitochondrial SHF is an important regulator of radioresistance in colorectal cancer cells, identifying SHF as a promising therapeutic target to enhance radiotherapy efficacy in colorectal cancer.

Keywords: Colorectal cancer; Mitochondrial DNA copy number; Mitochondrial function; Radioresistance; Radiosensitivity.

MeSH terms

  • Cell Line, Tumor
  • Colorectal Neoplasms* / genetics
  • Colorectal Neoplasms* / metabolism
  • Colorectal Neoplasms* / radiotherapy
  • DNA Copy Number Variations
  • DNA, Mitochondrial* / genetics
  • DNA-Binding Proteins
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Mitochondria
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism
  • Radiation Tolerance*

Substances

  • DNA, Mitochondrial
  • DNA-Binding Proteins
  • Intracellular Signaling Peptides and Proteins
  • Mitochondrial Proteins
  • SHF protein, human
  • SSBP1 protein, human